Quick Answer
BeOne Medicines Ltd. reported Cash And Cash Equivalents At Carrying Value of $4.55 billion for the year ending 2025.
- BeOne Medicines Ltd. showed an increase of +73.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from BeOne Medicines Ltd.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), BeOne Medicines Ltd.'s Cash And Cash Equivalents At Carrying Value has grown by 115,731.1%.
- Historical annual values: Fiscal year 2025: $4.55 billion | Fiscal year 2024: $2.63 billion | Fiscal year 2023: $3.17 billion | Fiscal year 2022: $3.87 billion | Fiscal year 2021: $4.38 billion | Fiscal year 2020: $1.38 billion | Fiscal year 2019: $618.01 million | Fiscal year 2018: $712.94 million | Fiscal year 2017: $239.60 million | Fiscal year 2016: $87.51 million | Fiscal year 2015: $17.87 million | Fiscal year 2014: $13.90 million | Fiscal year 2013: $3.93 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: